Navigation Links
Helix BioPharma shareholders vote in favour of management
Date:1/30/2008

lpha-2b and its novel L-DOS47 new drug candidate. Helix is listed on the TSX under the symbol "HBP" and quoted on the Frankfurt, Berlin, Munich and Stuttgart Stock Exchanges under the same symbol.

The Toronto Stock Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this News Release. This News Release contains forward-looking statements regarding the development of the Company's drug products, which statements can be identified by the words "looks forward, "development" and "developing". Actual results or events could differ materially from these forward-looking statements and information due to numerous factors, including without limitation, research & development risks, intellectual property risks; product liability risks; the risk of unanticipated expenses, the need for regulatory approvals which is not assured; the need for clinical trials and uncertainty whether they will occur or will be successful; and possible changes in business strategy or plans. These and other risks and uncertainties are contained in Helix's latest Annual Information Form at http://www.sedar.com. Forward-looking statements and information are based on the assumptions and expectations of Helix's management at the time they are made, and Helix does not assume any obligation, except as required by law, to update any forward-looking statement or information should those assumptions or expectations, or other circumstances change.


'/>"/>
SOURCE Helix BioPharma Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
2. Helix BioPharma Chairman resigns
3. Helix BioPharma Corp. announces fiscal 2007 results
4. Helix BioPharma Corp. announces management changes
5. Helix BioPharma announces $16.9 million private placement of common shares
6. Helix BioPharma announces Q1 2008 financial results
7. Helix BioPharma closes $16.9 million private placement of common shares
8. Helix BioPharma Corp. contracts KBI Biopharma to develop an L-DOS47 clinical packaging format
9. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
10. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
11. PDL BioPharma Announces Internal CEO Investigation Found No Credible Evidence of Improper Personal Conduct or Breach of Fiduciary Duty
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2014)... , Aug. 18, 2014 /PRNewswire/ - SQI Diagnostics Inc. (TSX-V: ... proprietary technologies and products for advanced microarray diagnostics, today ... Friday, August 22 at 2:00 pm ET.  ... will provide a brief review of SQI,s recent commercialization ... a diagnostics industry veteran recently appointed to the Board ...
(Date:8/18/2014)... 18, 2014 Global HIV Infection Drug ... announced by Reportstack. The rate of HIV infection and the ... declining note at a positive rate across the globe. It ... million in 2005 to 1.5 in 2013, with the rates ... such drastic changes in the infection rates has been the ...
(Date:8/18/2014)... Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), ... technologies are used to develop, manufacture and sell ... chemical, biopharmaceutical and industrial enzyme industries, announced today ... Form 10 with the U.S. Securities and Exchange ... http://photos.prnewswire.com/prnh/20110621/CL06708LOGO The Form 10 ...
(Date:8/16/2014)... grant from the Walmart Foundation to build a robotic ... the manufacturing costs of goods, allowing those goods to ... built overseas. , The Walmart U.S. Manufacturing Innovation Grant ... awards to seven research and development institutions at the ... the collaboration between Walmart, the U.S. Conference of Mayors ...
Breaking Biology Technology:SQI Diagnostics Announces Investor Conference Call with Dr. Allan Pronovost 2SQI Diagnostics Announces Investor Conference Call with Dr. Allan Pronovost 3Global HIV Infection Drug Market Overview 2Global HIV Infection Drug Market Overview 3Global HIV Infection Drug Market Overview 4Dyadic International Files Form 10 Registration Statement 2Dyadic International Files Form 10 Registration Statement 3Dyadic International Files Form 10 Registration Statement 4UT Arlington receives Walmart, Walmart Foundation innovation grant 2UT Arlington receives Walmart, Walmart Foundation innovation grant 3
... $40 Million ... , ... 18, 2010 -- DuPont announced plans to expand its cutting-edge plant genetics research to help ... in central Iowa with additional lab facilities and jobs focused on advanced plant genetics., , ...
... ... Voxel Tracker™ is first-of-its-kind , ... Pittsburgh, PA (Vocus) March 18, 2010 -- Celsense, Inc. ... The software, dubbed Voxel Tracker™, was designed to optimize the use of Celsense’ ...
... experimenters three years to believe, University of Michigan engineers ... twist ribbons of nanoparticles. The results are published ... Matter readily bends and twists light. That,s the mechanism ... the opposite interaction has rarely been observed, said Nicholas ...
Cached Biology Technology:DuPont to Expand Plant Genetics Research Facilities 2DuPont to Expand Plant Genetics Research Facilities 3Novel Imaging Software Released by Celsense Inc. 2Novel Imaging Software Released by Celsense Inc. 3Light twists rigid structures in unexpected nanotech finding 2Light twists rigid structures in unexpected nanotech finding 3
(Date:8/19/2014)... students in college biology and other science courses ... quantitative ways, and now they have a new ... the Life Sciences," published this month by Princeton ... Institute for Mathematical and Biological Synthesis (NIMBioS), teaches ... can be used to explore and explain biological ...
(Date:8/19/2014)... of UTSA researchers has been awarded a nearly $40,000 ... Training (NCPTT), an office of the National Park Service ... will fund a one-year study of the energy efficiency ... homes in hot, humid climates. , Radiant barriers are ... that reflect heat back, thereby reducing the amount of ...
(Date:8/19/2014)... a number of ways. They have an impressive ability ... After being struck by lightning, for example, a tree ... one major downside to life as a plant: They ... they live and therefore completely at the mercy of ... developed mechanisms that enable them to rapidly adapt their ...
Breaking Biology News(10 mins):New textbook introduces undergraduates to mathematics for the life sciences 2UTSA researcher awarded $38K+ to evaluate energy efficiency options for historic homes 2UTSA researcher awarded $38K+ to evaluate energy efficiency options for historic homes 3How steroid hormones enable plants to grow 2
... Surgical treatment for mitral valve disease includes either ... a metal, mechanical valve or an animal tissue valve. ... require a major incision in the chest. Now, after ... Medical Center in Baltimore conclude that minimally invasive mitral ...
... species in the Basque Country, and alternative to Pinus ... and Alonsotegui (Muro, 1975) where the eucalyptus, amongst other ... plantations such as those of eucalyptus came about in ... pulp industry. Blights and diseases arose as one of ...
... 28th, 2009 New prenatal tests for Down syndrome are soon ... States, yet telling an expectant couple that their child will ... physicians are trained for, claims research published in the ... decades of surveys and interviews, offers several recommendations for how ...
Cached Biology News:Study details safe, effective, minimally invasive mitral valve repair 2Study details safe, effective, minimally invasive mitral valve repair 3Canker disease in eucalyptus in the Basque Country 2Canker disease in eucalyptus in the Basque Country 3Canker disease in eucalyptus in the Basque Country 4How to deliver the news? New advice for doctors diagnosing prenatal Down syndrome 2How to deliver the news? New advice for doctors diagnosing prenatal Down syndrome 3
Rabbit polyclonal to SpUlp2 ( Abpromise for all tested applications). Antigen: Synthetic peptide: SNNERQSLSSGSND, corresponding to amino acids 622-635 of Schizosaccharomyces pombe SpUlp2...
Rabbit polyclonal to Factor IX ( Abpromise for all tested applications). entrezGeneID: 2158 SwissProtID: P00740...
Mouse monoclonal [CLB-SW16 (formerly 708)] to CD42d (rating: ****) ( Abpromise for all tested applications). entrezGeneID: 2814 SwissProtID: P40197...
ANTI-HUMAN CYTOKINES, GROWTH FACTORS (polyclonal rabbit (or goat) antibodies) Human TARC - Biotin...
Biology Products: